Skip to main content
Premium Trial:

Request an Annual Quote

Ingenium Pharmaceuticals and Tuebingen Link up on Eye Research

NEW YORK, April 16 - Ingenium Pharmaceuticals and the molecular genetics laboratory of the University Eye Hospital of Tuebingen, Germany, today announced a research collaboration to create animal models with defined gene alterations for research into the genes related to eye diseases.

 

Financial details were not disclosed.

 

The project will use Ingenium's genotyping platform to create mammalian models that carry alterations in target genes. The university researchers will use the models to characterize gene functions and screen for drugs for treatment of ocular neuropathies, such as glaucoma.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.